IQVIA Laboratories Discovery Sciences extends support to the earliest stages of drug development.
Public source
Publisher name
Public post
Discovery is now part of the IQVIA Laboratories story. Built on decades of scientific expertise and powered by advanced technologies, AI-assisted approaches, and clinica…
Company
IQVIA Laboratories
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001–5,000 employees
About IQVIA Laboratories
As a leading global drug discovery and development laboratory services organization, IQVIA Laboratories provides a broad range of central laboratory and specialty biomarker services, including genomics, immunoassays, flow cytometry, anatomic pathology, precision medicine assays, vaccine assays, ADME, and bioanalytical services. IQVIA Laboratories also brings extensive expertise in antibody drug discovery, biomarker discovery, and decentralized clinical trial laboratory solutions. With a commitment to scientific excellence and operational efficiency, IQVIA Laboratories supports the entire drug discovery and development lifecycle across diverse regions and regulatory landscapes, ensuring data integrity and optimizing research to bring life-changing therapies to patients faster.
See moreLatest activity
Latest activity from IQVIA Laboratories
23 signals
Research & Knowledge
IQVIA Laboratories published a white paper exploring risk-based, fit-for-purpose immunogenicity strategies to align testing with clinical relevance, molecule risk, and development goals.
Presence & Recognition
IQVIA Laboratories hosted an event featuring scientific presentations, poster sessions, expert panel discussions, and networking opportunities across the drug discovery community.
Presence & Recognition
IQVIA Laboratories is hosting a Grwat opportunity to connect with industry peers, academics, and scientists to discuss the future of drug discovery.
Discover more
Similar signals
Similar public activity from other companies.
Products & Services
Pharmaron
Pharmaron supports developers with comprehensive, regulatory-aligned preclinical services from first-in-animal to GLP studies.
Products & Services
LAXAI Life Sciences
LAXAI Life Sciences built around the thesis that integrated programs move 20-30% faster on average, IP continuity and process knowledge don't survive vendor handoffs, and sponsor companies with fewer, deeper CDMO relationships consistently outperform.
Products & Services
Curia
Curia has capacity for new mRNA programs in 2026 and 2027, with capabilities spanning mRNA drug substance development, clinical manufacturing, formulation, and fill-finish.
Products & Services
PSI CRO
PSI CRO Specialized Study Support Services works directly with sites to reduce burden through dedicated expertise across patient identification, recruitment, retention, imaging workflows, nuclear medicine operations, and other site-intensive activities.
Products & Services
Frontage Laboratories, Inc